UK-based biopharmaceutical company Prokarium has received two Notices of Allowan...
The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 fo...
Researchers from Northwestern and Case Western Reserve universities have develop...
Syndax has entered into a synthetic royalty funding agreement with Royalty Pharm...
Increasingly, injectable manufacturers recognise that to achieve maximum profita...
In an end-of-Phase II meeting, the FDA indicated support for accelerated approva...
The European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharm...
The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing ...
AbbVie has entered into a partnership and option-to-license agreement with Evolv...
Decentralized clinical trials are transforming medical research with more flexib...
The committee was not convinced that the benefit of Zynquista outweighed the ris...
Through a partnership, the NCCN is adapting its Harmonized Guidelines for cancer...
Verastem Oncology has concluded the rolling submission of a new drug application...
Roche first entered into an agreement with Orionis Biosciences in 2023 and paid ...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through...
Izervay by Astellas and Syfovre by Apellis are the major rivals in the United St...
